Latest News & Updates

Breaking News

  • 31 minutes ago

  • Simantini Singh Deo

NeuroSigma Launches Second-Generation Monarch eTNS System For Children With ADHD In The U.S.
Breaking News
Revagenix Promotes Peter Smith To Chief Scientific Officer To Lead Next Phase Of Growth

Simantini Singh Deo

Other trending news you may like to read

NeuroSigma Launches Second-Generation Monarch eTNS System For Children With ADHD In The U.S.

NeuroSigma launches second-generation Monarch eTNS System for children with ADHD in the U.S.

Simantini Singh Deo

Pharma Now

Revagenix Promotes Peter Smith To Chief Scientific Officer To Lead Next Phase Of Growth

Revagenix promotes Peter Smith to Chief Scientific Officer to lead its next phase of growth.

Simantini Singh Deo

Pharma Now

IMUNON Reports Positive Phase 2 Results For IMNN-001 In Advanced Ovarian Cancer Study

IMUNON reports positive Phase 2 results for IMNN-001 in advanced ovarian cancer study.

Simantini Singh Deo

Pharma Now

Akari Therapeutics And Whitehawk Therapeutics Partner To Advance Next-Generation ADC Cancer Treatments

Akari Therapeutics partners with Whitehawk Therapeutics to advance next-generation ADC cancer treatments.

Simantini Singh Deo

Pharma Now